Proteins can be modified in various ways and at various times to control their activities within the cell. The addition of a functional group after translation, known as posttranslational modification, can change the way a protein regulates gene transcription. For example, the addition of an acetyl group provides the opportunity for histones-DNA-packaging proteins from which chromatin is composed-to bind to motifs called bromodomains on the surface of chromatinassociated proteins. Although histones are among the bestcharacterized acetylated proteins, several transcription factors have also been found to be acetylated, providing an additional and often underappreciated layer of transcriptional control.
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Proteins can be modified in various ways and at various times to control their activities within the cell. The addition of a functional group after translation, known as posttranslational modification, can change the way a protein regulates gene transcription. For example, the addition of an acetyl group provides the opportunity for histones-DNA-packaging proteins from which chromatin is composed-to bind to motifs called bromodomains on the surface of chromatinassociated proteins. Although histones are among the bestcharacterized acetylated proteins, several transcription factors have also been found to be acetylated, providing an additional and often underappreciated layer of transcriptional control.
GATA1, the founding member of the GATA family of transcription factors, plays a central role in blood cell development, and mutations in GATA1 underlie rare blood disorders such as congenital anemias. Moreover, somatic mutations in GATA1 can cause certain types of leukemias in humans. GATA1 coordinates red blood cell development by activating key red cell-specific genes and repressing other genes involved in the proliferation of immature red blood cell precursors. The enzyme responsible for appending acetyl groups onto GATA1, called, CREB-binding protein, specifically acetylates a cluster of lysine residues near the GATA1 DNA-binding domains. The exact functional significance of this modification has remained unclear. We have previously shown that mutations of the major GATA1 acetylation sites impaired GATA1 binding to all examined cellular DNA target sites in vivo-without compromising the ability of GATA1 to accumulate in the nucleus or bind to nonchromatinized DNA templates in vitro (1). These findings suggested that acetylation performs a function that is specific within the context of native chromatin. Based on these findings, we examined whether acetylation facilitates the association of GATA1 with a factor that stabilizes its interaction with target genes packaged into chromatin.
Here, we show that acetylated GATA1 binds a protein known as Brd3, a member of the BET protein family that contains two tandem bromodomains (BD1 and BD2) and an extraterminal (ET) domain. Our results show that Brd3 and GATA1 physically interact in an acetylation-dependent manner. Genome-wide occupancy analysis by ChIP followed by massively parallel sequencing (ChIP-seq), a technique that measures the occupancy of a protein across the entire genome, in erythroid cells revealed that Brd3 is present at most GATA1-occupied regulatory DNA elements, including those at both GATA1-activated and GATA1-repressed genes. In contrast, although histone acetylation had been implicated in the recruitment of Brd3 to active genes (2), we find that it is a relatively poor predictor of Brd3 recruitment.
Interference with Brd3 function through the use of dominant interfering alleles or pharmacologic compounds that specifically bind to the bromodomains of Brd family proteins revealed that the GATA1-Brd3 interaction is required for the occupancy of both proteins on chromatin and for normal red cell-specific gene expression. Together, these findings suggest a mechanism by which Brd3 "reads" acetylated lysines on GATA1 to stabilize GATA1-dependent transcription factor complexes on chromatin (Fig. 1) . Recently, compounds that target Brd family proteins have been recognized for their potential as anticancer and anti-inflammatory agents (3) (4) (5) . Therefore, in addition to providing a mechanism by which acetylation regulates GATA1 activity, our work emphasizes the need to further characterize the binding profiles of Brd proteins to cellular targets so as to improve the selectivity of these compounds. Thus, our work may pave the way for future research that could ultimately lead to the development of better anticancer and anti-inflammatory drugs. The hematopoietic transcription factor GATA1 is acetylated on lysine clusters near its zinc finger domains (Left and Center). Acetylated GATA1 specifically binds to the first bromodomain of BET family member Brd3 (Right). The resulting Brd3-containing GATA1 complex is competent to stably bind to cognate WGATAR sites present in the regulatory regions of its target genes and regulate erythroid transcription. 
